For anyone interested in investing in the health-care space, JPMorgan's annual Health Care Conference has become one of the most important events of the year. We were not able to get to San Francisco this year, but one of our favorite Odd Lots guests, James van Geelen of CitriniResearch.com, was in attendance. He called into this week's episode of Lots More to tell us what the leading players in health care and medical technology are buzzing about right now — and he confirms that AI and GLP-1 weight loss drugs are at the top of everyone's mind."
See omnystudio.com/listener for privacy information.
How Brad Jacobs Will Invest $4.5 Billion to Reshape Building Supplies
The Theory That Explains Why Everyone Went Crazy
Lots More With Neil Dutta on a Looming Fed Policy Error
The American Entrepreneurs Who First Opened The Chinese Market
Why Tom Lee Thinks We Could See S&P 15,000 by 2030
CoreWeave's CSO on the Business of Building AI Datacenters
John Arnold on Why It's So Hard To Build Things in America
Evolving Money: Money Without Borders (Sponsored Content)
The Big Trade Underneath the Strangely Calm Surface of the S&P 500
What a 'Degen' Crypto Trader Really Does All Day
How Indonesia and China Cornered the Nickel Market
Elon Musk Dominates Outer Space Like Nobody Has Before
This Is How the Food Industry Is Preparing For a Post-Ozempic World
Lots More with Kyla Scanlon on the Economic Vibes
Orsted's Americas CEO on Fixing What Went Wrong in Wind Power
Corporations Learned The Maximum Amount They Can Charge For a Product
Lots More on the Two Troubled NYC Office Buildings Everyone's Talking About
The Big Problem With the Modern Electricity Grid
Are We Doing Decarbonization Totally the Wrong Way?
How a Professional Sports Bettor Really Makes Money
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
TED Radio Hour
FT Alphachat
Freakonomics Radio
Goldman Sachs Exchanges
Slate Money